日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Seroprevalence and associated factors for hepatitis B and hepatitis C viral infection among patients with diabetes mellitus in Northern Tanzania

坦桑尼亚北部糖尿病患者乙型肝炎和丙型肝炎病毒感染的血清流行率及相关因素

Eliah, Doreen T; Chamba, Nyasatu G; Sadiq, Abid M; Mwasamwaja, Amos O; Kimondo, Faustini C; Matay, Cuthbert D; Nziku, Eliada B; Mirai, Tumaini E; Muhina, Ibrahim Ali Ibrahim; Said, Fuad H; Gharib, Sarah K; Lyamuya, Furaha S; Mkwizu, Elifuraha W; Kilonzo, Kajiru G; Maro, Venance P; Shao, Elichilia R

Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro

氟修饰有助于新型中枢神经系统靶向HIV-1蛋白酶抑制剂在体外对高度耐药的HIV-1病毒产生强效抗病毒活性,并赋予其良好的血脑屏障穿透性能。

Amano, Masayuki; Yedidi, Ravikiran S; Salcedo-Gómez, Pedro Miguel; Hayashi, Hironori; Hasegawa, Kazuya; Martyr, Cuthbert D; Ghosh, Arun K; Mitsuya, Hiroaki

Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications

新型中枢神经系统 (CNS) 靶向蛋白酶抑制剂,用于治疗耐药性 HIV 感染和 HIV 相关 CNS 并发症

Masayuki Amano, Pedro Miguel Salcedo-Gómez, Ravikiran S Yedidi, Rui Zhao, Hironori Hayashi, Kazuya Hasegawa, Tomofumi Nakamura, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya

GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants

GRL-079是一种新型HIV-1蛋白酶抑制剂,对多重耐药HIV-1变异株具有极强的抑制作用,并且具有很高的遗传屏障,能够有效防止耐药变异株的出现。

Delino, Nicole S; Aoki, Manabu; Hayashi, Hironori; Hattori, Shin-Ichiro; Chang, Simon B; Takamatsu, Yuki; Martyr, Cuthbert D; Das, Debananda; Ghosh, Arun K; Mitsuya, Hiroaki

Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants

设计和开发以冠状氧三环核心为P2配体的高效HIV-1蛋白酶抑制剂,以对抗多重耐药HIV变异株

Ghosh, Arun K; Rao, Kalapala Venkateswara; Nyalapatla, Prasanth R; Osswald, Heather L; Martyr, Cuthbert D; Aoki, Manabu; Hayashi, Hironori; Agniswamy, Johnson; Wang, Yuan-Fang; Bulut, Haydar; Das, Debananda; Weber, Irene T; Mitsuya, Hiroaki

Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies

以氨基双四氢呋喃衍生物为P2配体设计HIV-1蛋白酶抑制剂以增强骨架结合相互作用:合成、生物学评价和蛋白质-配体X射线研究

Ghosh, Arun K; Martyr, Cuthbert D; Osswald, Heather L; Sheri, Venkat Reddy; Kassekert, Luke A; Chen, Shujing; Agniswamy, Johnson; Wang, Yuan-Fang; Hayashi, Hironori; Aoki, Manabu; Weber, Irene T; Mitsuya, Hiroaki

C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir

C-5 修饰的四氢吡喃并四氢呋喃衍生的蛋白酶抑制剂 (PI) 可有效抑制对各种 PI(包括达芦那韦)具有高度耐药性的 HIV-1 变体的复制

Manabu Aoki, Hironori Hayashi, Ravikiran S Yedidi, Cuthbert D Martyr, Yuki Takamatsu, Hiromi Aoki-Ogata, Teruya Nakamura, Hirotomo Nakata, Debananda Das, Yuriko Yamagata, Arun K Ghosh, Hiroaki Mitsuya

TiCl4-promoted tandem carbonyl or imine addition and Friedel-Crafts cyclization: synthesis of benzo-fused oxabicyclooctanes and nonanes

TiCl4促进的串联羰基或亚胺加成和傅克环化反应:苯并稠合氧杂双环辛烷和壬烷的合成

Ghosh, Arun K; Martyr, Cuthbert D; Xu, Chun-Xiao